Related Experiment Video
Updated: May 6, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
The molecular basis of hereditary complement factor I deficiency
T J Vyse1, B J Morley, I Bartok
1Department of Medicine, RPMS, Hammersmith Hospital, London, United Kingdom.
Abstract:
The molecular basis of hereditary complement factor I deficiency is described in two pedigrees. In one pedigree, there were two factor I-deficient siblings, one of whom was asymptomatic and the other suffered from recurrent pyogenic infections. Their factor I mRNA was analyzed by reverse transcription of fibroblast RNA followed by amplification using the polymerase chain reaction. Both siblings were homozygous for the same transversion (adenine to thymine) at nucleotide 1282 in the cDNA. This mutation causes histidine-400 to be replaced by leucine. The altered histidine is a semi-conserved residue within the serine proteinase family, although no function has been ascribed to it. The proband of the second pedigree studied was found to be a compound heterozygote. One allele had the same mutation as the first family, the second allele had a donor splice site mutation that resulted in the deletion of the mRNA encoded in the fifth exon (a low-density lipoprotein receptor domain) from its transcript.
Insights
Hereditary complement factor I deficiency results from specific genetic mutations. These mutations impact factor I mRNA, leading to varied clinical presentations, from asymptomatic to recurrent infections.
Area of Science:
- Immunogenetics
- Molecular Medicine
- Biochemistry
Background:
- Hereditary complement factor I deficiency is a rare genetic disorder affecting the immune system.
- Complement factor I plays a crucial role in regulating the complement cascade, preventing excessive immune responses.
- Understanding the molecular basis of this deficiency is key to diagnosing and potentially treating associated infections.
Purpose of the Study:
- To elucidate the molecular basis of hereditary complement factor I deficiency in two distinct pedigrees.
- To identify specific genetic mutations responsible for complement factor I deficiency.
- To correlate genotype with clinical phenotype in affected individuals.
Main Methods:
- Analysis of complement factor I mRNA using reverse transcription and polymerase chain reaction (RT-PCR).
- DNA sequencing to identify specific nucleotide substitutions and splice site mutations.
- Genotyping of affected individuals within two pedigrees.
Main Results:
- Identified a transversion mutation (adenine to thymine at nucleotide 1282) in both siblings of the first pedigree, leading to a histidine-400 to leucine substitution.
- The proband of the second pedigree was a compound heterozygote, carrying the same transversion mutation on one allele.
- The second allele in the second pedigree exhibited a donor splice site mutation, causing the deletion of exon 5 (encoding a low-density lipoprotein receptor domain) from the transcript.
Conclusions:
- Specific mutations in the complement factor I gene underlie hereditary deficiency.
- The identified mutations, including a missense mutation and a splice site mutation, disrupt factor I function.
- Genotype-phenotype correlations highlight the importance of complement factor I in preventing pyogenic infections.
More Related Videos
12:24Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Complement System